Immune Caps Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth 68.35%
- Profit Growth 107.59%
- Ebitda 55.11%
- Net Worth 146.68%
- Total Assets 49.19%
About Immune Caps
Immune Caps Private Limited (ICPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2017 (Seven years and five months 10 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Shambhu Singh and Madanprasad Chaudhary serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2017PTC299330
-
Company No.
299330
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Sep 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Immune Caps?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shambhu Singh
|
Director | 04-Sep-2017 | Current |
|
Madanprasad Chaudhary
|
Director | 04-Sep-2017 | Current |
Financial Performance of Immune Caps.
Immune Caps Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 68.35% increase. The company also saw a substantial improvement in profitability, with a 107.59% increase in profit. The company's net worth Soared by an impressive increase of 146.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Immune Caps?
In 2020, Immune Caps had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rhomboid Finguru Private LimitedShambhu Singh is a mutual person
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Feb 2023 | Idbi Bank Limited | ₹2.00 M | Open |
| 14 Mar 2018 | Idbi Bank Limited | ₹1.00 M | Open |
How Many Employees Work at Immune Caps?
Unlock and access historical data on people associated with Immune Caps, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Immune Caps, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immune Caps's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.